IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 62 filers reported holding IRADIMED CORP in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $754 | -99.3% | 17 | -99.2% | 0.00% | – |
| Q2 2023 | $103,835 | +266143.6% | 2,175 | +217400.0% | 0.00% | – |
| Q1 2023 | $39 | -99.6% | 1 | -99.7% | 0.00% | – |
| Q4 2022 | $10,892 | +55.6% | 385 | +63.8% | 0.00% | – |
| Q3 2022 | $7,000 | -68.2% | 235 | -63.3% | 0.00% | – |
| Q2 2022 | $22,000 | -45.0% | 640 | -28.9% | 0.00% | – |
| Q1 2022 | $40,000 | -46.7% | 900 | -44.3% | 0.00% | – |
| Q4 2021 | $75,000 | +212.5% | 1,616 | +122.9% | 0.00% | – |
| Q3 2021 | $24,000 | +166.7% | 725 | +125.9% | 0.00% | – |
| Q2 2021 | $9,000 | -10.0% | 321 | -18.1% | 0.00% | – |
| Q1 2021 | $10,000 | -60.0% | 392 | -64.4% | 0.00% | – |
| Q4 2020 | $25,000 | +316.7% | 1,100 | +290.1% | 0.00% | – |
| Q3 2020 | $6,000 | -66.7% | 282 | -63.2% | 0.00% | – |
| Q2 2020 | $18,000 | -53.8% | 766 | -58.2% | 0.00% | – |
| Q1 2020 | $39,000 | +85.7% | 1,831 | +100.8% | 0.00% | – |
| Q4 2019 | $21,000 | +90.9% | 912 | +79.5% | 0.00% | – |
| Q3 2019 | $11,000 | -56.0% | 508 | -58.9% | 0.00% | – |
| Q2 2019 | $25,000 | -7.4% | 1,236 | +26.5% | 0.00% | – |
| Q1 2019 | $27,000 | +42.1% | 977 | +27.0% | 0.00% | – |
| Q4 2018 | $19,000 | -47.2% | 769 | -20.1% | 0.00% | – |
| Q3 2018 | $36,000 | +260.0% | 963 | +91.1% | 0.00% | – |
| Q2 2018 | $10,000 | -71.4% | 504 | -86.1% | 0.00% | – |
| Q3 2017 | $35,000 | -74.6% | 3,631 | -77.4% | 0.00% | – |
| Q2 2017 | $138,000 | +45.3% | 16,082 | +50.8% | 0.00% | – |
| Q1 2017 | $95,000 | -50.0% | 10,664 | -37.6% | 0.00% | – |
| Q4 2016 | $190,000 | +3066.7% | 17,103 | +5051.5% | 0.00% | – |
| Q3 2016 | $6,000 | -33.3% | 332 | -18.2% | 0.00% | – |
| Q2 2016 | $9,000 | -76.3% | 406 | -79.8% | 0.00% | – |
| Q1 2016 | $38,000 | +3700.0% | 2,012 | +8647.8% | 0.00% | – |
| Q4 2015 | $1,000 | 0.0% | 23 | -62.9% | 0.00% | – |
| Q3 2015 | $1,000 | 0.0% | 62 | +67.6% | 0.00% | – |
| Q2 2015 | $1,000 | – | 37 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 140,752 | $3,290,000 | 3.17% |
| RK Capital | 222,914 | $5,212,000 | 1.95% |
| Nine Ten Capital Management LLC | 130,272 | $3,046,000 | 0.76% |
| Parkman Healthcare Partners LLC | 93,500 | $2,186,000 | 0.63% |
| Ranger Investment Management | 244,963 | $5,727,000 | 0.38% |
| CADENCE CAPITAL MANAGEMENT LLC | 107,043 | $2,503,000 | 0.27% |
| ALGERT GLOBAL LLC | 29,652 | $693,000 | 0.21% |
| Mondrian Investment Partners LTD | 163,939 | $3,833,000 | 0.10% |
| NAVELLIER & ASSOCIATES INC | 20,800 | $486,000 | 0.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 56,811 | $1,328,000 | 0.04% |